BackAngion Biomedica Overview

Angion Biomedica Long Term Debt

Angion Biomedica's long-term debt is $3.8M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$3.82M
21.42% YoYΔ $-1.04M vs prior year quarter

Peer average

Loading

Angion Biomedica Long Term Debt History

Loading

Angion Biomedica vs. peers: Long Term Debt Comparison

Loading

Angion Biomedica Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Angion Biomedica (ANGN) FAQ

As of the most recent data (March 2026), ANGN shows a long-term debt of $3.8M. That compares with $4.9M in the prior-year period — down 21.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANGN's long-term debt is now $3.8M (was $4.9M) — a 21.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Angion Biomedica is outperforming or lagging.

Tracking ANGN's long-term debt over time shows whether Angion Biomedica is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8M That compares with $4.9M in the prior-year period — down 21.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Angion Biomedica's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $3.8M) with ownership activity and broader fundamentals.

Angion Biomedica's long-term debt is $3.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.